NasdaqCM - Delayed Quote USD
PolyPid Ltd. (PYPD)
2.7500
+0.0100
+(0.36%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-21,963
-21,963
-17,236
-34,317
-32,386
Investing Cash Flow
-330
-330
3,804
16,575
36,900
Financing Cash Flow
32,416
32,416
9,976
16,428
1,034
End Cash Position
15,809
15,809
5,686
9,142
10,456
Income Tax Paid Supplemental Data
3
3
18
8
--
Interest Paid Supplemental Data
950
950
1,038
734
--
Capital Expenditure
-76
-76
-196
-1,767
-2,993
Issuance of Capital Stock
35,863
35,863
8,723
4,423
--
Issuance of Debt
--
--
--
11,711
--
Repayment of Debt
-3,322
-3,322
-2,618
-402
--
Free Cash Flow
-22,039
-22,039
-17,432
-36,084
-35,379
12/31/2021 - 6/26/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
M8W.F MediWound Ltd.
15.60
+0.65%
ORGS Orgenesis Inc.
2.4900
+12.67%
NXOA.BE Nicox SA
0.2275
+0.66%
23J0.F ProMIS Neurosciences, Inc.
0.5150
-4.63%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
1BT.F Enlivex Therapeutics Ltd.
0.7950
+1.92%
GON.DU Geron Corp
1.2080
-1.31%
0M4.DU Mersana Therapeutics Inc
0.3351
-0.89%